Alkaloid AD’s groundbreaking formulation of ready-to-use liquid Omeprazole, a value-added drug representing the world’s first of its kind, has been awarded the 2023 Patent of the Year by the State Office of Industrial Property. This recognition was revealed during the celebrations commemorating World Intellectual Property Day on April 26th.

"Maintaining a high standard of corporate culture, result-driven focus and strong ethical standards is a significant challenge for any successful and ambitious company. Alkaloid consistently endeavors to attract top talent from the labor market, irrespective of the role in question.”

Alkaloid AD Skopje donates liquid Omeprazole worth 12.5 million MKD to aid the treatment of approximately 200 children - patients of PHI University Clinic for Pediatric Diseases and PHI University Clinic for Respiratory Diseases in Children - Kozle

The recent construction of solid pharmaceutical form manufacturing facilities covering an area of 6200 square meters, marks the most significant investment made by the company in the past two decades.

This year, Alkaloid is hosting the "1st Cefixime Global Meeting", scheduled to take place from March 14th to 16th in Istanbul, Turkey.